Leonardo Rojas

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Niki Karachaliou, Imane Chaib, Andrés F. Cardona et al. · EBioMedicine · 2018 · 77 citations · Full text

Common Co-activation, Medicine, Pathology +9

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón et al. · Lung Cancer · 2018 · 60 citations

Tumor Biology, Medicine, Pathology +8

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona et al. · Thoracic Cancer · 2019 · 60 citations · Full text

Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma

Andrés F. Cardona, Leonardo Rojas, Beatriz Wills et al. · Journal of Neuro-Oncology · 2017 · 43 citations

Neuro-oncology, Medicine, Hispanic Patients +9

Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation

Andrés F. Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruíz-Patiño et al. · Journal of Neuro-Oncology · 2021 · 43 citations

Egfrviii Mutation, Neuro-oncology, Simultaneous Egfr Amplification +9